Great managers can make all the difference to your career and your day to day experience at work. At ICON, our managers play an important role in supporting people to grow, share their expertise and build confidence in ...
Designing the future
Regulatory readiness for next-generation AI-enabled software as a medical device (SaMD)
Read the whitepaperFrom here to where?
Plotting a course to bring APAC-developed drugs to the world
Read the whitepaperGlobal regulatory strategies for immunology
Success factors for hypercompetitive therapy
Read the whitepaper
Featured 168澳洲幸运5官网结果记录体彩网站solutions
Orbis
ICON’s multi-agent platform that connects human expertise, data and AI across the clinical trial lifecycle.
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Manufacturing & Pharmacy Services
Rapid small batch formulation, manufacturing, labelling and distribution for clinical trials.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON168体彩澳洲幸运5开奖结果
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
PV
regulatory intelligence
Stay compliant throughout any local or global regulatory change.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Oncology
Explore how ICON supports oncology development with faster start‑up and predictable delivery.
168网幸运5彩票官方网号码记录澳洲5直
Insights into first-in-human study design of oligonucleotides
Watch the webinar.
When patients lead: Breaking barriers in ultra-rare disease drug development
Watch the webinar.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.
